Innovative Eyewear Series A Warrants 8/16/27 (LUCYW) Financials
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 14, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the LUCYW SEC filings page.
Innovative Eyewear, Inc. Series A Warrants 8/16/27 (LUCYW) reported $2.7M in revenue for fiscal year 2025, up 62.6% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Revenue is scaling and gross margins are recovering, but overhead still turns product contribution into persistent large cash losses.
In FY2025, revenue grew62.6% while gross-profit margin expanded 8.2 percentage points, showing that improved unit economics were not merely a by-product of stagnant demand. Yet SG&A rose14.2% and the company still posted a net loss of$7.6M , so margin recovery has not covered the operating cost base.
The business turned a gross profit of
A 9.0x current ratio and liabilities equal to
Financial Health Signals
Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Innovative Eyewear, Inc. Series A Warrants 8/16/27's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Innovative Eyewear, Inc. Series A Warrants 8/16/27 held $6.5M in cash, cash equivalents and investments at the end of fiscal year 2025, and its operations used $7.3M of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and Innovative Eyewear, Inc. Series A Warrants 8/16/27 scores 34/100 among other emerging companies.
Innovative Eyewear, Inc. Series A Warrants 8/16/27 had 6M shares outstanding at the end of fiscal year 2025. Dilution ranks emerging companies on how fast that count has grown over three years, where a slower rise is the better one, and Innovative Eyewear, Inc. Series A Warrants 8/16/27 scores 81/100 among other emerging companies.
Innovative Eyewear, Inc. Series A Warrants 8/16/27 spent $725K on research and development in fiscal year 2025, which was 6.6% of its operating costs that year. R&D Intensity ranks emerging companies on the share of operating costs that goes into research, and Innovative Eyewear, Inc. Series A Warrants 8/16/27 scores 28/100 among other emerging companies.
Innovative Eyewear, Inc. Series A Warrants 8/16/27 reported revenue of $2.7M in fiscal year 2025, against $1.6M in fiscal year 2024. Revenue Progress ranks emerging companies on the three-year path of that line, and Innovative Eyewear, Inc. Series A Warrants 8/16/27 scores 79/100 among other emerging companies.
Innovative Eyewear, Inc. Series A Warrants 8/16/27's operations used $7.3M of cash in fiscal year 2025, against $6.7M used in fiscal year 2024. Burn Trend ranks emerging companies on which way that figure has moved over three years, and Innovative Eyewear, Inc. Series A Warrants 8/16/27 scores 36/100 among other emerging companies.
Innovative Eyewear, Inc. Series A Warrants 8/16/27's cash, cash equivalents and investments came to $6.5M at the end of fiscal year 2025, against $1.1M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and Innovative Eyewear, Inc. Series A Warrants 8/16/27 scores 91/100 among other emerging companies.
Innovative Eyewear, Inc. Series A Warrants 8/16/27 passes 4 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.
Innovative Eyewear, Inc. Series A Warrants 8/16/27 reported a net loss of $7.6M while operations used $7.3M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Key Financial Metrics
Earnings & Revenue
Innovative Eyewear, Inc. Series A Warrants 8/16/27 generated $1.0M in revenue in Q2 2026. This represents an increase of 74.5% from the same quarter a year earlier. Against the prior quarter it is up 30.6%.
Innovative Eyewear, Inc. Series A Warrants 8/16/27 reported a net loss of $1.7M in Q2 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Innovative Eyewear, Inc. Series A Warrants 8/16/27 earned -$0.26 per diluted share (EPS) in Q2 2026. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Not reported for Q2 2026.
Cash & Balance Sheet
Innovative Eyewear, Inc. Series A Warrants 8/16/27 held $2.5M in cash as of Q2 2026; no long-term debt figure is on record for that period.
Not reported for Q2 2026.
Not reported for Q2 2026.
Margins & Returns
Innovative Eyewear, Inc. Series A Warrants 8/16/27's gross margin was 24.0% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is up 26.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.3 percentage points.
Innovative Eyewear, Inc. Series A Warrants 8/16/27's quarterly ROE was -24.2% in Q2 2026: one quarter's net income over shareholder equity, not annualized. This is down 5.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 3.4 percentage points.
Not reported for Q2 2026.
Not shown for Q2 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Capital Allocation
Innovative Eyewear, Inc. Series A Warrants 8/16/27 invested $142K in research and development in Q2 2026. This represents a decrease of 47.0% from the same quarter a year earlier. Against the prior quarter it is up 2.9%.
Not reported for Q2 2026.
Not reported for Q2 2026.
LUCYW Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.0M+74.5% | $774K+70.2% | $960K+39.0% | $668K+163.5% | $579K+87.6% | $455K+18.5% | $691K+12.2% | $254K+14.3% |
| Cost of Revenue | $768K+29.8% | $598K+155.6% | $845K+41.6% | $423K+117.9% | $592K+133.5% | $234K-37.9% | $597K-25.0% | $194K+37.3% |
| Gross Profit | $243Kn/m | $175K-20.4% | $115K+22.4% | $245K+312.6% | -$13K-123.0% | $221K+3072.7% | $94Kn/m | $59K-26.1% |
| R&D Expenses | $142K-47.0% | $138K-34.4% | $117K-45.7% | $130K-1.1% | $268K+4.4% | $211K-2.6% | $215K+77.9% | $131K-31.8% |
| SG&A Expenses | $1.8M-4.6% | $2.4M+26.4% | $2.5M+22.1% | $2.0M+20.9% | $1.9M+6.8% | $1.9M+6.1% | $2.0M-6.6% | $1.7M+14.2% |
| Income Tax | $0n/m | $0n/m | N/A | $0n/m | $0n/m | $0n/m | N/A | $0n/m |
| Net Income | -$1.7Mn/m | -$2.3Mn/m | -$1.9Mn/m | -$1.8Mn/m | -$2.1Mn/m | -$1.8Mn/m | -$2.1Mn/m | -$1.7Mn/m |
| EPS (Basic) | -$0.26 | -$0.37 | -$0.28 | -$0.38 | -$0.66 | -$0.72 | -$0.41 | -$0.99 |
| EPS (Diluted) | -$0.26 | -$0.37 | -$0.28 | -$0.38 | -$0.66 | -$0.72 | -$0.41 | -$0.99 |
| Diluted Shares (Avg) | 6M | 6M | N/A | 5M | 3M | 2M | N/A | 2M |
Not reported in any period shown, so not listed: Operating Income, EBITDA, Interest Expense.
LUCYW Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $7.5M-37.4% | $9.5M+19.4% | $10.1M+3.1% | $11.2M-3.6% | $11.9M+51.9% | $7.9M+65.0% | $9.8M+58.2% | $11.6M+42.9% |
| Current Assets | $6.8M-40.1% | $8.7M+19.4% | $9.4M+2.1% | $10.6M-3.6% | $11.3M+55.5% | $7.3M+78.3% | $9.2M+64.5% | $11.0M+46.5% |
| Cash & Equivalents | $2.5M-67.8% | $4.4M-16.7% | $6.5M+147.7% | $6.7M+47.4% | $7.6M+29.3% | $5.3M+98.5% | $2.6M-38.7% | $4.5M+16.4% |
| Short-Term Investments | $0-100.0% | $0n/m | $0-100.0% | $0-100.0% | $1.3Mn/m | $0n/m | $4.9Mn/m | $4.9M+151.1% |
| Inventory | $1.8M+5.7% | $1.4M+24.5% | $1.7M+109.8% | $1.6M+78.4% | $1.7M+80.2% | $1.1M+31.3% | $832K+56.0% | $915K+17.9% |
| Accounts Receivable | $136K+135.4% | $72K-20.3% | $142K+31.7% | $83K+3.1% | $58K-5.9% | $90K+69.9% | $108K+15.8% | $81K-36.6% |
| Long-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Total Liabilities | $574K-12.8% | $1.1M+148.4% | $1.1M+44.5% | $925K+38.9% | $659K+27.8% | $447K-50.9% | $743K+12.6% | $666K+40.6% |
| Current Liabilities | $563K-7.2% | $1.1M+143.9% | $1.0M+41.7% | $885K+35.5% | $606K+22.5% | $447K-49.4% | $738K+18.1% | $653K+51.4% |
| Non-Current Liabilities | $12K-77.8% | $20Kn/m | $28K+422.7% | $40K+211.6% | $52K+156.5% | $0-100.0% | $5K-84.6% | $13K-69.5% |
| Total Equity | $6.9M-38.8% | $8.4M+11.7% | $9.1M-0.3% | $10.3M-6.2% | $11.3M+53.6% | $7.5M+92.1% | $9.1M+63.6% | $10.9M+43.0% |
| Retained Earnings | -$36.3Mn/m | -$34.6Mn/m | -$32.3Mn/m | -$30.5Mn/m | -$28.6Mn/m | -$26.5Mn/m | -$24.7Mn/m | -$22.6Mn/m |
Not reported in any period shown, so not listed: Goodwill, Long-Term Debt.
LUCYW Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$1.9Mn/m | -$2.5Mn/m | -$1.4Mn/m | -$1.5Mn/m | -$2.1Mn/m | -$2.3Mn/m | -$1.9Mn/m | -$1.4Mn/m |
| Depreciation & Amortization | $8K-50.9% | $12K-45.5% | $13K-47.2% | $15K-37.7% | $17K-55.2% | $21K-2.1% | $26K+69.5% | $24K+196.9% |
| Stock-Based Compensation | N/A | $201K+13.2% | N/A | N/A | N/A | $178K-23.5% | N/A | N/A |
| Capital Expenditures | N/A | N/A | $17K-35.6% | $15Kn/m | $0-100.0% | $41K+25.9% | $26K | $0-100.0% |
| Free Cash Flow | N/A | N/A | -$1.4Mn/m | -$1.5Mn/m | -$2.1Mn/m | -$2.4Mn/m | -$2.0M | -$1.4Mn/m |
| Investing Cash Flow | -$27Kn/m | -$1.0M-121.2% | $825Kn/m | -$15Kn/m | -$1.3Mn/m | $4.9Mn/m | -$61K-103.1% | -$5.0Mn/m |
| Financing Cash Flow | -$32K | $1.4M | $337K+275.0% | $584K-88.4% | N/A | N/A | $90Kn/m | $5.0Mn/m |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
LUCYW Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 24.0%+26.2pp | 22.7%-25.8pp | 12.0%-1.6pp | 36.6%+13.2pp | -2.2%-20.1pp | 48.5%+46.7pp | 13.6%+42.8pp | 23.4%-12.8pp |
| Net Margin | -165.3% | -298.5% | -194.8% | -274.8% | -363.6% | -391.4% | -307.8% | -678.5% |
| Return on Equity | -24.2%-5.5pp | -27.6%-3.9pp | -20.6%+2.7pp | -17.9%-2.2pp | -18.7%+7.8pp | -23.7%+26.8pp | -23.4%+19.7pp | -15.7%+4.6pp |
| Return on Assets | -22.4%-4.7pp | -24.4%-2.0pp | -18.4%+3.2pp | -16.4%-1.6pp | -17.6%+7.1pp | -22.4%+18.6pp | -21.6%+16.9pp | -14.8%+4.3pp |
| Current Ratio | 12.06-6.6x | 8.02-8.4x | 9.03-3.5x | 11.98-4.9x | 18.70+4.0x | 16.39+11.7x | 12.52+3.5x | 16.83-0.6x |
| Liabilities-to-Equity | 0.080.0x | 0.13+0.1x | 0.120.0x | 0.090.0x | 0.060.0x | 0.06-0.2x | 0.080.0x | 0.060.0x |
| Asset Turnover | 0.14+0.1x | 0.080.0x | 0.090.0x | 0.060.0x | 0.050.0x | 0.060.0x | 0.070.0x | 0.020.0x |
| FCF Margin | N/A | N/A | -142.5% | -226.3% | -365.4% | -517.4% | -285.2% | -551.9% |
Not reported in any period shown, so not listed: Operating Margin, Debt-to-Equity.
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Net Margin, FCF Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Innovative Eyewear, Inc. Series A Warrants 8/16/27 LUCYW | FY2025 | $2.7M | -$7.6M | N/A | N/A | 58/100 |
| NexGel, Inc Warrant NXGLW | FY2025 | $11.4M | -$3.0M | -26.3% | N/A | 38/100 |
| Innovative Eyewear, Inc. LUCY | FY2025 | $2.7M | -$7.6M | N/A | $7.2M | 58/100 |
| Milestone Scientific, Inc. MLSS | FY2025 | $9.0M | -$5.7M | -63.8% | $28.7M | 40/100 |
Where Innovative Eyewear, Inc. Series A Warrants 8/16/27 Ranks
Frequently Asked Questions
What is Innovative Eyewear, Inc. Series A Warrants 8/16/27's annual revenue?
Innovative Eyewear, Inc. Series A Warrants 8/16/27 (LUCYW) reported $2.7M in total revenue for fiscal year 2025. This represents a 62.6% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Innovative Eyewear, Inc. Series A Warrants 8/16/27's revenue growing?
Innovative Eyewear, Inc. Series A Warrants 8/16/27 (LUCYW) revenue grew by 62.6% year-over-year, from $1.6M to $2.7M in fiscal year 2025.
Is Innovative Eyewear, Inc. Series A Warrants 8/16/27 profitable?
No, Innovative Eyewear, Inc. Series A Warrants 8/16/27 (LUCYW) reported a net loss of $7.6M in fiscal year 2025.
What is Innovative Eyewear, Inc. Series A Warrants 8/16/27's gross margin?
Innovative Eyewear, Inc. Series A Warrants 8/16/27 (LUCYW) had a gross margin of 21.3% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Innovative Eyewear, Inc. Series A Warrants 8/16/27's return on equity (ROE)?
Innovative Eyewear, Inc. Series A Warrants 8/16/27 (LUCYW) has a return on equity of -83.7% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Innovative Eyewear, Inc. Series A Warrants 8/16/27's free cash flow?
Innovative Eyewear, Inc. Series A Warrants 8/16/27 (LUCYW) recorded an outflow of $7.3M in free cash flow during fiscal year 2025. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Innovative Eyewear, Inc. Series A Warrants 8/16/27's operating cash flow?
Innovative Eyewear, Inc. Series A Warrants 8/16/27 (LUCYW) recorded an outflow of $7.3M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are Innovative Eyewear, Inc. Series A Warrants 8/16/27's total assets?
Innovative Eyewear, Inc. Series A Warrants 8/16/27 (LUCYW) had $10.1M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Innovative Eyewear, Inc. Series A Warrants 8/16/27's capital expenditures?
Innovative Eyewear, Inc. Series A Warrants 8/16/27 (LUCYW) invested $73K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Innovative Eyewear, Inc. Series A Warrants 8/16/27 spend on research and development?
Innovative Eyewear, Inc. Series A Warrants 8/16/27 (LUCYW) invested $725K in research and development during fiscal year 2025.
What is Innovative Eyewear, Inc. Series A Warrants 8/16/27's current ratio?
Innovative Eyewear, Inc. Series A Warrants 8/16/27 (LUCYW) had a current ratio of 9.03 as of fiscal year 2025, which is generally considered healthy.
What is Innovative Eyewear, Inc. Series A Warrants 8/16/27's liabilities-to-equity ratio?
Innovative Eyewear, Inc. Series A Warrants 8/16/27 (LUCYW) had a liabilities-to-equity ratio of 0.12 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity. No debt-to-equity ratio is shown for fiscal year 2025, because the filing data we hold for that year carries no long-term debt figure.
What is Innovative Eyewear, Inc. Series A Warrants 8/16/27's return on assets (ROA)?
Innovative Eyewear, Inc. Series A Warrants 8/16/27 (LUCYW) had a return on assets of -74.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
How does Innovative Eyewear, Inc. Series A Warrants 8/16/27's liquidity compare with its operating cash outflow?
At the end of fiscal year 2025, Innovative Eyewear, Inc. Series A Warrants 8/16/27 (LUCYW) held $6.5M in cash, cash equivalents and investments, and reported an operating cash outflow of $7.3M over that year. Dividing the one by the other, the reported balance equals about 11 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
What is Innovative Eyewear, Inc. Series A Warrants 8/16/27's Piotroski F-Score?
Innovative Eyewear, Inc. Series A Warrants 8/16/27 (LUCYW) has a Piotroski F-Score of 4 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Innovative Eyewear, Inc. Series A Warrants 8/16/27's earnings high quality?
Innovative Eyewear, Inc. Series A Warrants 8/16/27 (LUCYW) reported a net loss of $7.6M while operations used $7.3M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Innovative Eyewear, Inc. Series A Warrants 8/16/27?
Innovative Eyewear, Inc. Series A Warrants 8/16/27 (LUCYW) scores 58 out of 100 on our Financial Health Score, indicating moderate standing within its emerging companies peer group. The score is the average of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.